These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7691443)
21. Determination of prostate-specific antigen in serum by immunoradiometric assay. Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745 [TBL] [Abstract][Full Text] [Related]
22. Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum. Morris DL; Dillon PW; Very DL; Ng P; Kish L; Goldblatt JL; Bruzek DJ; Chan DW; Ahmed MS; Witek D; Fritsche HA; Smith C; Schwartz D; Schwartz MK; Noteboom JL; Vessella RL; Yeung KK; Allard WJ J Clin Lab Anal; 1998; 12(1):65-74. PubMed ID: 9484672 [TBL] [Abstract][Full Text] [Related]
23. Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology. Soukka T; Antonen K; Härmä H; Pelkkikangas AM; Huhtinen P; Lövgren T Clin Chim Acta; 2003 Feb; 328(1-2):45-58. PubMed ID: 12559598 [TBL] [Abstract][Full Text] [Related]
24. Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening. Hoffman BR; Yu H; Diamandis EP Clin Chem; 1996 Apr; 42(4):536-44. PubMed ID: 8605670 [TBL] [Abstract][Full Text] [Related]
25. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734 [TBL] [Abstract][Full Text] [Related]
26. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Ferguson RA; Yu H; Kalyvas M; Zammit S; Diamandis EP Clin Chem; 1996 May; 42(5):675-84. PubMed ID: 8653891 [TBL] [Abstract][Full Text] [Related]
27. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. Klee GG; Dodge LA; Zincke H; Oesterling JE J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749 [TBL] [Abstract][Full Text] [Related]
28. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. Prestigiacomo AF; Lilja H; Pettersson K; Wolfert RL; Stamey TA J Urol; 1996 Aug; 156(2 Pt 1):350-4. PubMed ID: 8683677 [TBL] [Abstract][Full Text] [Related]
30. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy? Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160 [TBL] [Abstract][Full Text] [Related]
32. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer. Tello FL; Prats CH; González MD Clin Chem Lab Med; 2001 Feb; 39(2):116-20. PubMed ID: 11341744 [TBL] [Abstract][Full Text] [Related]
33. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin. España F; Sánchez-Cuenca J; Estellés A; Gilabert J; Griffin JH; Heeb MJ Clin Chem; 1996 Apr; 42(4):545-50. PubMed ID: 8605671 [TBL] [Abstract][Full Text] [Related]
34. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870 [TBL] [Abstract][Full Text] [Related]
35. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml. Okihara K; Fritsche HA; Ayala A; Johnston DA; Allard WJ; Babaian RJ J Urol; 2001 Jun; 165(6 Pt 1):1930-6. PubMed ID: 11371884 [TBL] [Abstract][Full Text] [Related]
36. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595 [TBL] [Abstract][Full Text] [Related]
37. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum. Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989 [TBL] [Abstract][Full Text] [Related]
38. Serum-based ALYGNSA immunoassay for the prostate cancer biomarker, total prostate-specific antigen (tPSA). Mackness BC; McDonald MJ Anal Bioanal Chem; 2010 Aug; 397(7):3151-4. PubMed ID: 20556365 [TBL] [Abstract][Full Text] [Related]
39. Use of a new hypersensitive assay for the detection of prostate specific antigen in prostate cancer. Arai Y; Onishi H; Oishi K; Takeuchi H; Yoshida O Jpn J Clin Oncol; 1993 Apr; 23(2):110-5. PubMed ID: 7685834 [TBL] [Abstract][Full Text] [Related]
40. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]